13F-HR filed by GREAT POINT PARTNERS LLC
GREAT POINT PARTNERS LLC filed this 13F-HR for the quarter ended 2023-09-30, filed 2023-11-14, with 42 holding rows worth $549,036,939.
- Accession
- 0001172661-23-004025
- Filer
- CIK 1281446
- Filed
- 2023-11-14
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q3 2023
A holdings report, 42 entries on the cover page, a total value of $549,036,939 stated on the cover page (in dollars after the unit check, H1), rows summing to $549,036,939 with VALUE read as dollars as filed, 13F file number 028-11743. The quarter's positions are built on this report. The resolved quarter.
Other managers
- included managerJAY JEFFREY R028-12517
- included managerYehudai Ortav028-20398
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| UROGEN PHARMA LTD | M96088105 | COMMON STOCK | 2,620,545 | $36,713,835 | dollars as filed | |
| ALPINE IMMUNE SCIENCES INC | 02083G100 | COM | 3,078,633 | $35,250,348 | dollars as filed | |
| PLIANT THERAPEUTICS INC | 729139105 | COM | 1,755,184 | $30,434,891 | dollars as filed | |
| VAXCYTE INC COM | 92243G108 | Stock | 531,211 | $27,081,137 | dollars as filed | |
| ULTRAGENYX PHARMACEUTICAL IN | 90400D108 | COM | 727,426 | $25,932,737 | dollars as filed | |
| ALKERMES PLC | G01767105 | SHS | 875,044 | $24,509,982 | dollars as filed | |
| RAPT THERAPEUTICS INC | 75382E109 | COM | 1,458,070 | $24,233,123 | dollars as filed | |
| ZURA BIO LTD | G9TY5A101 | COMMON STOCK | 3,295,000 | $21,747,000 | dollars as filed | |
| SAREPTA THERAPEUTICS INC | 803607100 | COM | 165,200 | $20,025,544 | dollars as filed | |
| EVOLUS INC | 30052C107 | COM | 2,186,934 | $19,988,577 | dollars as filed | |
| POINT BIOPHARMA GLOBAL INC | 730541109 | COM | 2,909,960 | $19,409,433 | dollars as filed | |
| CYTOKINETICS INC | 23282W605 | COM NEW | 600,000 | $17,676,000 | dollars as filed | |
| XENON PHARMACEUTICALS INC COM | 98420N105 | Stock | 500,001 | $17,080,034 | dollars as filed | |
| ANAPTYSBIO INC | 032724106 | COM | 894,333 | $16,062,221 | dollars as filed | |
| IMMUNOCORE HLDGS PLC ADS | 45258D105 | ADR | 290,917 | $15,098,592 | dollars as filed | |
| AEROVATE THERAPEUTICS INC | 008064107 | COM | 1,091,233 | $14,808,032 | dollars as filed | |
| INTRA-CELLULAR THERAPIES INC | 46116X101 | COMMON STOCK | 225,000 | $11,720,250 | dollars as filed | |
| ACLARIS THERAPEUTICS INC COM | 00461U105 | Stock | 1,691,768 | $11,588,611 | dollars as filed | |
| SAREPTA THERAPEUTICS INC | 803607100 | COM | 95,000 | $11,515,900 | dollars as filed | put |
| PTC THERAPEUTICS INC | 69366J200 | COM | 500,000 | $11,205,000 | dollars as filed | |
| REPLIMUNE GROUP INC | 76029N106 | COMMON STOCK | 638,495 | $10,924,649 | dollars as filed | |
| OPTINOSE INC | 68404V100 | COM | 8,839,939 | $10,873,125 | dollars as filed | |
| AMICUS THERAPEUTICS INC | 03152W109 | COM | 857,000 | $10,421,120 | dollars as filed | |
| ARCELLX INC COMMON STOCK | 03940C100 | Stock | 287,500 | $10,315,500 | dollars as filed | |
| KARUNA THERAPEUTICS INC | 48576A100 | COM | 60,500 | $10,229,945 | dollars as filed | |
| AKERO THERAPEUTICS INC | 00973Y108 | COM | 198,500 | $10,040,130 | dollars as filed | |
| INSMED INC COM PAR $.01 | 457669307 | Stock | 394,872 | $9,970,518 | dollars as filed | |
| RENEO PHARMACEUTICALS INC | 75974E103 | COM | 1,167,061 | $8,887,170 | dollars as filed | |
| APOGEE THERAPEUTICS INC COM | 03770N101 | Stock | 400,000 | $8,520,000 | dollars as filed | |
| GOSSAMER BIO INC COM | 38341P102 | Stock | 6,230,272 | $5,188,571 | dollars as filed | |
| IGM BIOSCIENCES INC | 449585108 | COM | 615,317 | $5,137,897 | dollars as filed | |
| HERON THERAPEUTICS INC | 427746102 | COM | 4,737,368 | $4,879,489 | dollars as filed | |
| ACLARIS THERAPEUTICS INC COM | 00461U105 | Stock | 700,000 | $4,795,000 | dollars as filed | call |
| CEREVEL THERAPEUTICS HLDNG I | 15678U128 | COM | 215,000 | $4,693,450 | dollars as filed | |
| ACUMEN PHARMACEUTICALS INC | 00509G209 | CMN | 1,074,101 | $4,457,519 | dollars as filed | |
| GENERATION BIO CO | 37148K100 | COM | 1,022,537 | $3,875,415 | dollars as filed | |
| MIRATI THERAPEUTICS INC | 60468T105 | COM | 86,302 | $3,759,315 | dollars as filed | |
| TERNS PHARMACEUTICALS INC COM | 880881107 | Stock | 645,899 | $3,248,872 | dollars as filed | |
| TALARIS THERAPEUTICS INC | 87410C104 | COM | 1,000,000 | $2,810,000 | dollars as filed | |
| GRACELL BIOTECHNOLOGIES INC | 38406L103 | ADR | 579,667 | $1,669,441 | dollars as filed | |
| SOLID BIOSCIENCES INC | 83422E204 | COMMON STOCK | 450,403 | $1,135,016 | dollars as filed | |
| AMBRX BIOPHARMA, INC. SPONSORED ADR | 02290A102 | COM | 97,700 | $1,123,550 | dollars as filed | call |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001172661-23-004025 | this filing | 2023-11-14 | acceptance time not in the bulk data set |